Cannabidiol, a major phytocannabinoid, as a potent atypical inhibitor for CYP2D6.

@article{Yamaori2011CannabidiolAM,
  title={Cannabidiol, a major phytocannabinoid, as a potent atypical inhibitor for CYP2D6.},
  author={Satoshi Yamaori and Yasuka Okamoto and Ikuo Yamamoto and Kazuhito Watanabe},
  journal={Drug metabolism and disposition: the biological fate of chemicals},
  year={2011},
  volume={39 11},
  pages={2049-56}
}
Δ(9)-Tetrahydrocannabinol, cannabidiol (CBD), and cannabinol are the three major cannabinoids contained in marijuana, which are devoid of nitrogen atoms in their structures. In this study, we investigated the inhibitory effects of the major phytocannabinoids on the catalytic activity of human CYP2D6. These major cannabinoids inhibited the 3-[2-(N,N-diethyl-N-methylammonium)ethyl]-7-methoxy-4-methylcoumarin (AMMC) and dextromethorphan O-demethylase activities of recombinant CYP2D6 and pooled… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 4 times. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 24 extracted citations

Molecular Targets of Cannabidiol in Neurological Disorders

Neurotherapeutics • 2015
View 3 Excerpts
Highly Influenced

References

Publications referenced by this paper.
Showing 1-10 of 41 references

Potency trends

Z Mehmedic, S Chandra, +6 authors MA ElSohly
2010
View 4 Excerpts
Highly Influenced

The utility of in vitro cytochrome P450 inhibition data in the prediction of drug-drug interactions.

The Journal of pharmacology and experimental therapeutics • 2006
View 3 Excerpts
Highly Influenced

Integrated in vitro analysis for the in vivo prediction of cytochrome P450-mediated drug-drug interactions.

Drug metabolism and disposition: the biological fate of chemicals • 2008
View 1 Excerpt
Highly Influenced

Comparative metabolic capabilities and inhibitory profiles of CYP2D6.1, CYP2D6.10, and CYP2D6.17.

Drug metabolism and disposition: the biological fate of chemicals • 2007
View 1 Excerpt
Highly Influenced

Pharmacokinetics and pharmacodynamics of cannabinoids.

Clinical pharmacokinetics • 2003
View 2 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…